finance.yahoo.com

FDA Approves Roche-Developed Blood Test for Alzheimer’s Signs

Eli Lilly logoEli Lilly
Sig3.35Sen+5.20Env0.00Soc+3.75Gov+0.35

Eli Lilly secured FDA approval for Elecsys pTau217, a Roche-developed blood test that detects an Alzheimer-associated biomarker in adults 55 and older with cognitive decline. The result supports whether brain changes are likely or unlikely but is not a standalone diagnosis. By reducing reliance on costly scans or spinal-fluid tests, the approval could improve access to earlier screening as therapies roll out.

Coverage (1)

ABOUT

What is Fimmer?

Most feeds treat all company headlines the same. An executive interview, an office closure, stock analysis, and a data breach can sit side by side with no sense of scale. Fimmer ranks coverage by what matters, so important events stand out and signals are prioritised over noise. We cluster related company news and score each story using a range of metrics, so you see the most crucial stories first.

SCORING

What do the scores mean?

Significance (0–10) measures the scale of the real-world impact. Sentiment and ESG (−10 to +10) indicate the tone of the coverage and whether the change relates to environmental, social, or governance factors. Together, these scores help distinguish meaningful developments from routine company news. More information about our scoring methodology can be found on our About page.

DISCOVERY

Explore more on Fimmer

Search more than 10,000 public companies, browse the company index, explore their scores, and read the coverage behind them, with our core features available to everyone for free.

For more advanced features, Pro gives you access to dynamic feeds, custom sorting, and more ways to track the companies that matter to you.

More with Pro